Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Injection drug use provides an efficient mechanism for transmitting bloodborne viruses, including human immunodeficiency virus (HIV) and hepatitis C virus (HCV). Effective targeting of resources for prevention of HIV and HCV infection among persons who inject drugs (PWID) is based on knowledge of the population size and disparity in disease burden among PWID. This study estimated the number of PWID in the United States to calculate rates of HIV and HCV infection. METHODS: We conducted meta-analysis using data from 4 national probability surveys that measured lifetime (3 surveys) or past-year (3 surveys) injection drug use to estimate the proportion of the United States population that has injected drugs. We then applied these proportions to census data to produce population size estimates. To estimate the disease burden among PWID by calculating rates of disease we used lifetime population size estimates of PWID as denominators and estimates of HIV and HCV infection from national HIV surveillance and survey data, respectively, as numerators. We calculated rates of HIV among PWID by gender-, age-, and race/ethnicity. RESULTS: Lifetime PWID comprised 2.6% (95% confidence interval: 1.8%-3.3%) of the U.S. population aged 13 years or older, representing approximately 6,612,488 PWID (range: 4,583,188-8,641,788) in 2011. The population estimate of past-year PWID was 0.30% (95% confidence interval: 0.19 %-0.41%) or 774,434 PWID (range: 494,605-1,054,263). Among lifetime PWID, the 2011 HIV diagnosis rate was 55 per 100,000 PWID; the rate of persons living with a diagnosis of HIV infection in 2010 was 2,147 per 100,000 PWID; and the 2011 HCV infection rate was 43,126 per 100,000 PWID. CONCLUSION: Estimates of the number of PWID and disease rates among PWID are important for program planning and addressing health inequities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The proportion of candidemia patients with an IDU history is much higher than the estimated <1% of the entire U.S. population with a history of IDU during the previous 12 months (55)”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [55]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 2×
“5% population proportion of PWID in Puerto Rico, Puerto Rico population totals from census data [16], and the estimated number of PWID living with diagnosed HIV infection in Puerto Rico in 2010 from CDC’s HIV case surveillance data [5].”
BackgroundMethodFixed-and random-effects models in meta-analysis.
Hedges, L. V., & Vevea, J. L. (1998) · Psychological Methods · doi:10.1037/1082-989x.3.4.486 · Cited by 2,977 · cited 1×
“We selected random effects models for our analyses because the models assume the studies are a random sample [15], a type of inference that fits the purpose of our study.”
MethodThe Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
(1998) · PsycEXTRA Dataset · doi:10.1037/e547602006-001 · Cited by 1,213
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Smith, B. D., Morgan, R. L., Beckett, G. A., Falck-Ytter, Y. T., Holtzman, D. J., Teo, C., Jewett, A., Baack, B. N., Rein, D. B., Patel, N., et al. (2012) · PubMed · Cited by 991
Self-citationLyons, S. J., Johnson, A. S., Hu, X., Yu, C., Jin, C., Wu, B., Li, J., Chong, M., Hawkins, D., Wang, S., et al. (2017) · Cited by 636
Mohaghegh, H. (2014) · Journal of Liver · doi:10.4172/2167-0889.1000147 · Cited by 609
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.
Holmberg, S. D. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.642 · Cited by 539 · cited 1×
“PWID among the nation as a whole and for large metropolitan areas [7–10].”
Background
Cited by
Items 101–200 of 239
Park, J. N., Owczarzak, J., Urquhart, G. J., Morris, M., Weicker, N. P., Rouhani, S., & Sherman, S. G. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03381-y · Cited by 19
Marotta, P. L., Stringer, K., Beletsky, L., West, B. S., Goddard-Eckrich, D., Gilbert, L., Hunt, T., Wu, E., & El-Bassel, N. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00565-6 · Cited by 15
“5 million people who inject drugs (PWID) of which an estimated 1 million recently injected drugs [21].”
BackgroundMaragh‐Bass, A. C., Powell, C., Park, J. N., Flynn, C. P., & German, D. (2016) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2016.1196629 · Cited by 17
“For example, Shapiro and colleagues recently evaluated primary care approaches to substance use treatment and found that while referral for specialty addiction treatment is recommended for patients with substance dependence disorders, primary care physicians with training and support can provide some or all of these s…”
BackgroundInfluentialAdams, J. W., Savinkina, A. A., Hudspeth, J. C., Gai, M. J., Jawa, R., Marks, L. R., Linas, B. P., Hill, A., Flood, J., Kimmel, S. D., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0541 · Cited by 17
Handel, M. M. V., Lyons, B. H., Oraka, E., Nasrullah, M., DiNenno, E. A., & Dietz, P. M. (2015) · AIDS Patient Care and STDs · doi:10.1089/apc.2015.0078 · Cited by 15
Goyal, R., Hu, C., Klein, P. W., Hotchkiss, J. R., Morris, E., Mandsager, P., Cohen, S. M., Luca, D. L., Gao, J., Jones, A., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002546 · Cited by 15
Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?
Perlman, D. C., Jarlais, D. C. D., & Feelemyer, J. P. (2015) · Journal of Addictive Diseases · doi:10.1080/10550887.2015.1059111 · Cited by 16
RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk
Tobin, K. E., Davey-Rothwell, M. A., Nonyane, B. A. S., Knowlton, A. R., Wissow, L. S., & Latkin, C. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187180 · Cited by 15
Factors associated with chronic pain and non-medical opioid use among people who inject drugs
Bicket, M. C., Park, J. N., Torrie, A. M., Allen, S. T., Weir, B. W., & Sherman, S. G. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106172 · Cited by 16
Wesson, P., Mirzazadeh, A., & McFarland, W. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy132 · Cited by 15
Koenig, L. J., Lyles, C. M., Higa, D. H., Mullins, M. M., & Sipe, T. A. (2021) · Public Health Reports · doi:10.1177/0033354920988871 · Cited by 16
Trends in HIV Infection Among Persons Who Inject Drugs: United States and Puerto Rico, 2008–2013
Mitsch, A., Hall, H. I., & Babu, A. S. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303380 · Cited by 14
Self-citationKazemian, P., Costantini, S., Neilan, A. M., Resch, S., Walensky, R. P., Weinstein, M. C., & Freedberg, K. A. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103475 · Cited by 13
Krebs, E., Zang, X., Enns, B., Min, J. E., Behrends, C. N., del Río, C., Dombrowski, J. C., Feaster, D. J., Gebo, K. A., Marshall, B. D. L., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa130 · Cited by 16
“6%) [6] underscore how the public health response and short supply of these services have been (and remain) inadequate in many settings [1, 7, 8].”
BackgroundWelch-Lazoritz, M. L., Hautala, D. S., Habecker, P., & Dombrowski, K. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.08.001 · Cited by 13
“Of the 6.6 million current or former injection drug users in the United States (U.S.) in 2011, it is estimated that 2.85 million were living with Hepatitis C and 141,970 were living with HIV (Lansky et al., 2014).”
BackgroundInfluentialRapoport, A. B., Fine, D. R., Manne‐Goehler, J., Herzig, S. J., & Rowley, C. F. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab009 · Cited by 13
“The opioid use and overdose crisis has had a devastating impact on communities across the United States [1], where it is estimated that >750 000 persons inject drugs annually [2].”
BackgroundCan hepatitis C elimination targets be sustained among people who inject drugs post-2030?
Delaunay, C. L., Godin, A., Kronfli, N., Panagiotoglou, D., Cox, J., Alary, M., Klein, M. B., & Maheu‐Giroux, M. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103343 · Cited by 14
Allen, S. T., Schneider, K. E., Morris, M., Rouhani, S., Harris, S. J., Saloner, B. K., & Sherman, S. G. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00746-5 · Cited by 13
“In the United States (US), there are an estimated 750,000 people who injected drugs in the past year [5].”
BackgroundTrends in Injection Drug Use Among High School Students, U.S., 1995–2013
Klevens, R. M., Jones, S. E., Ward, J. W., Holtzman, D. J., & Kann, L. K. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.05.026 · Cited by 13
“, ever IDU is lower among black non-Hispanics than among white non-Hispanics.(25) Despite the increasing trend over time in IDU among black non-Hispanic students in this study, no significant difference was found in the prevalence of ever IDU by race/ethnicity in 2013.”
BackgroundSelf-citationPreventing transitions into injection drug use: A call for gender-responsive upstream prevention
Meyers‐Pantele, S. A., Smith, L. R., & Werb, D. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102836 · Cited by 14
“While women who inject drugs (WWID) comprise roughly a quarter to a third of North American PWID, they have been found to experience riskier substance use-related trajectories than men who inject drugs (Iverson, Page, Madden & Maher, 2015; Lansky et al., 2014).”
BackgroundLee, T., Buchanan, A. L., Katenka, N., Forastiere, L., Halloran, M. E., Friedman, S. R., & Nikolopoulos, G. K. (2023) · The Annals of Applied Statistics · doi:10.1214/22-aoas1713 · Cited by 21
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond
Barnett, B. S., Wakeman, S. E., Davis, C. S., Favaro, J., & Rich, J. D. (2021) · American Journal of Public Health · doi:10.2105/ajph.2021.306228 · Cited by 13
Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs
Young, S., Wood, E., Dong, H., Kerr, T. H., & Hayashi, K. (2015) · Addiction · doi:10.1111/add.13256 · Cited by 12
“5% of the world’s population, they account for approximately 5–10% of all people living with HIV infection (1).”
BackgroundCoronado-García, M., Thrash, C. R., Welch-Lazoritz, M. L., Gauthier, R., Reyes, J. C., Khan, B., & Dombrowski, K. (2017) · PubMed · Cited by 12
Neaigus, A., Reilly, K. H., Jenness, S. M., Hagan, H., Wendel, T., Gelpí-Acosta, C., & Marshall, D. M. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001407 · Cited by 15
“Median number of PWID social network members (interquartile ranges) 10 (6, 24) 15 (7, 30) 27 (13, 50) S.”
Ohringer, A. R., Serota, D. P., McLean, R. L., Stockman, L. J., & Watt, J. (2021) · BMC Public Health · doi:10.1186/s12889-021-11492-3 · Cited by 12
Córdova, D., Lua, F. M., Ovadje, L., Hong, E., Castillo, B., & Salas‐Wright, C. P. (2017) · JMIR Public Health and Surveillance · doi:10.2196/publichealth.7129 · Cited by 13
“Injection drug use (IDU), conversely, is a direct and efficient mechanism for the transmission and acquisition of HIV [53].”
Sell, J. K., & Visconti, A. (2020) · Family Medicine · doi:10.22454/fammed.2020.443447 · Cited by 12
Singh, S., France, A. M., Chen, Y.-H., Farnham, P. G., Oster, A. M., & Gopalappa, C. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021109 · Cited by 12
Weiser, J. K., Garg, S., Beer, L., & Skarbinski, J. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx003 · Cited by 11
Pieper, B. A. (2019) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000559612.06067.55 · Cited by 11
“6 million persons in 2011.(1) Heroin tends to be the most common injected drug, and its use has increased across most demographic groups in the US, from 1.”
BackgroundSyringe Coverage Among People Who Inject Drugs in West Virginia, USA
Allen, S. T., White, R. H., O’Rourke, A., Schneider, K. E., Weir, B. W., Lucas, G. M., Kilkenny, M. E., & Sherman, S. G. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03247-3 · Cited by 11
Wilkerson, J. M., Paola, A. D., McCurdy, S., & Schick, V. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106327 · Cited by 11
Blach, S., Brown, K., Brown, R. S., Gholam, P. M., Terrault, N. A., Estes, C., & Razavi, H. A. (2022) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2022.11.021 · Cited by 10
Mirzazadeh, A., Evans, J. L., Hahn, J. A., Jain, J. P., Briceño, A., SHIBOSKI, S. C., Lum, P. J., Bentsen, C. G., Davis, G., Shriver, K., et al. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1988-y · Cited by 10
“[42] estimated 55 per 100,000 PWID in a literature review of U.”
Cotton fever resulting in Enterobacter asburiae endocarditis
Francis, M., Chin, J., Lomiguen, C. M., & Glaser, A. (2019) · IDCases · doi:10.1016/j.idcr.2019.e00688 · Cited by 11
“While the ailment of “Cotton Fever” is widely acknowledged amongst PWIDs, it is rarely recognized in the medical community and less than a dozen cases have been presented in peer-reviewed literature [4–7].”
BackgroundInfluentialJarlais, D. C. D., Arasteh, K., McKnight, C. A., Feelemyer, J. P., Tross, S., Perlman, D. C., Friedman, S. R., & Campbell, A. N. C. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303787 · Cited by 10
Bobashev, G., Mars, S. G., Murphy, N. R., Dreisbach, C., Zule, W. A., & Ciccarone, D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215042 · Cited by 12
A good “doctor” is hard to find: Assessing uncredentialed expertise in assisted injection
Brothers, S. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.112446 · Cited by 10
Roth, A. M., Bartholomew, T. S., Ward, K., Groves, A. K., Mazzella, S., Bellamy, S. L., Amico, K. R., Carrico, A. W., Ironson, G. H., & Krakower, D. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae450 · Cited by 9
“Injection drug use has increased dramatically in the United States; the estimated number of adults injecting drugs increased from 775 000 in 2011 to more than 3 600 000 in 2018 [1, 2].”
Mackesy‐Amiti, M. E., Boodram, B., Spiller, M. W., Paz‐Bailey, G., Prachand, N., Broz, D., & for the NHBS Study Group (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001406 · Cited by 9
“Practice how to prepare for safe injections?” Based on these items, we created 4 variables as indicators of (1) individual didactic intervention (discussed safe injecting practices oneon-one), (2) individual practical skills intervention (practiced preparing for safe injection one-on-one), (3) group didactic intervent…”
BackgroundMethodSelf-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients
Hernández, D., Feaster, D. J., Gooden, L. K., Douaihy, A. B., Mandler, R. N., Erickson, S. J., Kyle, T. L., Haynes, L. F., Schwartz, R. P., Das, M., et al. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1074-2 · Cited by 9
Characteristics of late recurrent candidemia in adult patients
Ala‐Houhala, M., & Anttila, V. (2021) · Mycoses · doi:10.1111/myc.13236 · Cited by 11
“001 Prior GI surgery within 30 days 3 (15) 73 (24) .”
BackgroundIs your syringe services program cost-saving to society? A methodological case study
Jarlais, D. C. D., Feelemyer, J. P., McKnight, C. A., Knudtson, K., & Glick, S. N. (2021) · Harm Reduction Journal · doi:10.1186/s12954-021-00575-4 · Cited by 9
Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico
Habecker, P., Abadie, R., Welch-Lazoritz, M. L., Reyes, J. C., Khan, B., & Dombrowski, K. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1400562 · Cited by 9
“Furthermore, considering that the disease itself remains asymptomatic for many years, it is not unreasonable that PWID would have different attitudes towards HCV than towards faster acting diseases such as HIV (Lansky et al., 2014; Rhodes & Treloar, 2008).”
Infective Endocarditis Among Women Who Inject Drugs
Adams, J. A., Spence, C., Shojaei, E., Thandrasisla, P., Gupta, A. K., Choi, Y., Skinner, S., & Silverman, M. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.37861 · Cited by 11
Making the case for harm reduction programs for injection drug users
Kulikowski, J., & Linder, E. A. (2018) · Nursing · doi:10.1097/01.nurse.0000532745.80506.17 · Cited by 8
Estévez-Lamorte, N., Foster, S., Gmel, G. E., & Mohler‐Kuo, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111158 · Cited by 11
“In fact, these previous investigations [4,5,21] included subjects in various age categories (i.”
BackgroundTookes, H., Oxner, A. Z., Serota, D. P., Alonso, E., Metsch, L. R., Feaster, D. J., Ucha, J., Suarez, E., Forrest, D. W., McCollister, K. E., et al. (2023) · Trials · doi:10.1186/s13063-023-07074-w · Cited by 8
Moorman, A. C., Bixler, D., Teshale, E. H., Hofmeister, M. G., Roberts, H., Chapin-Bardales, J., & Gupta, N. (2023) · Public Health Reports · doi:10.1177/00333549231181348 · Cited by 8
Characterizing latent classes of social support among persons who inject drugs
Sacamano, P. L., Mehta, S. H., Latkin, C. A., Falade-Nwulia, O. O., Kirk, G. D., & Rudolph, A. E. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107816 · Cited by 8
“6 million) of persons aged 13 years and older (Lansky et al., 2014).”
BackgroundÁlvarez, E., Joshi, S., Lokker, C., Wang, A. R., Pavalagantharajah, S., Qiu, Y., Sidhu, H., Mbuagbaw, L. C. E., Qutob, M., Henedi, A., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035188 · Cited by 8
Perumalswami, P., & Talal, A. H. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix682 · Cited by 8
Lin, Q., Aguilera, J. A. R., Williams, L. D., Mackesy‐Amiti, M. E., Latkin, C. A., Piñeros, J., Kolak, M., & Boodram, B. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104217 · Cited by 10
“It is estimated that there were around 3.7 million people who inject drugs (PWID) in the U.S. in 2018 (Bradley et al., 2022), representing a 5-fold increase since the previous estimate from 2011 (Lansky et al., 2014).”
InfluentialQuantifying Syringe Exchange Program Operational Space in the District of Columbia
Allen, S. T., Ruiz, M. S., & Jones, J. A. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1405-y · Cited by 7
“6 % (approximately 6,612,488 persons) of the population has ever injected drugs [1].”
BackgroundJanssen, É. (2017) · Journal of Public Health · doi:10.1093/pubmed/fdx059 · Cited by 7
Abadie, R., & Dombrowski, K. (2020) · Harm Reduction Journal · doi:10.1186/s12954-020-00421-z · Cited by 7
Narouee, S., Shati, M., Nasehi, M., & Dadgar, F. (2019) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.33.158 · Cited by 7
Soria, J., Johnson, T., Collins, J. D., Corby-Lee, G., Thacker, J. R., White, C., Hoven, A. D., & Thornton, A. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103255 · Cited by 6
Cancer Screening among Rural People Who Use Drugs: Colliding Risks and Barriers
Jenkins, W. D., Rose, J., Molina, Y., Lee, M., Bolinski, R. S., Luckey, G., & Ham, B. V. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19084555 · Cited by 6
Chiosi, J. J., Mueller, P. P., Chhatwal, J., & Ciaranello, A. L. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09773-1 · Cited by 6
“Target estimates for HIV incidence from 2015 to 2019 were calculated by the annual number of new HIV infections attributed to IDU divided by an estimated number of active PWID without HIV (Supplement Table B2) [5, 26].”
MethodThe Importance of Population Denominators for High-Impact Public Health for Marginalized Populations
Purcell, D. W., Hall, H. I., Bernstein, K. T., Gift, T. L., McCray, E., & Mermin, J. (2016) · JMIR Public Health and Surveillance · doi:10.2196/publichealth.5883 · Cited by 6
“…the gap in national, population-wide denominators by using various analytic techniques to estimate the US population size of MSM [4], persons who inject drugs [5], and high-risk heterosexuals [6], and to estimate the population size of MSM and persons who inject drugs by urbanicity and region [7].”
BackgroundHayes, B. T., Favaro, J., Coello, D., Behrends, C. N., Jakubowski, A. U., & Fox, A. D. (2021) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2021.103474 · Cited by 8
A mathematical model of HCV transmission dynamics with sex stratification and environmental effects
Helikumi, M., Mushanyu, J., & Mhlanga, A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0336374 · Cited by 5
“It has also been seen that the rate of current illicit drug use is higher for males than for females and males are more likely than females to be current users of several different illicit drugs [59].”
Pharmacy Access to Sterile Injection Supplies for People Who Inject Drugs
Barnett, B. S., & Morris, N. P. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.6840 · Cited by 5
Paulus, K., Kelly, P. J. A., Brajuha, J. A., D’Avanzo, P. A., Dauria, E., Trainor, A., Alrez, A., & Bass, S. B. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02452-7 · Cited by 5
Purcell, M., Gnilopyat, S., Makwana, B., & Narayanan, S. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf259 · Cited by 7
“There are approximately 4.5 to 6.6 million people who inject drugs (PWID) in the United States, which represents approximately 1.8% to 3.3% of the population [1].”
InfluentialJenkins, W. D., Beach, L. B., Rodriguez, C. A., & Choat, L. (2020) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1716683 · Cited by 5
“…HIV, nearly 2.3 million new STIs in 2017, approximately 12 million have misused opioids at some point during the preceding year (3.7% prevalence), and an estimated 2.6% of adults inject drugs (Lansky et al. 2014; Centers for Disease Control and Prevention 2017a; Administration SAaMHS 2017, 2018).”
BackgroundInfluentialKenney, S. R., Anderson, B. J., Bailey, G. L., & Stein, M. D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000482 · Cited by 6
“These descriptive normative perceptions were compared with data retrieved from national data sources (SAMHSA, 2016) and a meta-analysis using national data sources (Lansky et al., 2014).”
MethodDwivedi, N., Breslin, M. A., McDermott, A., Lin, S., Vallier, H. A., & Tornetta, P. (2020) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000001330 · Cited by 5
“Amid this economic backdrop of inflationary healthcare costs, opioid and intravenous drug use (IVDU) has evolved into a national epidemic in the United States [19, 24].”
BackgroundInfluentialReducing Risky Drug Use Behaviors by Enrolling Syringe Exchange Registrants in Methadone Maintenance
KIDORF, M. S., Brooner, R. K., Leoutsakos, J., & Peirce, J. M. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1887253 · Cited by 5
“Well over 700,000 people in the United States inject heroin and other opioids, including fentanyl (Lansky et al., 2014).”
BackgroundLa santé sexuelle des hommes trans : entre problèmes de catégorisation et invisibilisation
Rivest, P. (2023) · Santé Publique · doi:10.3917/spub.hs2.0037 · Cited by 5
Tom, C. K., Huang, G., Kovalic, A. J., Davis, K., & Peacock, J. E. (2021) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115453 · Cited by 6
Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia
Allen, S. T., Mazhnaya, A., O’Rourke, A., White, R. H., Wedlock, P. T., Grieb, S. M. D., Kilkenny, M. E., Walls, M. L., & Sherman, S. G. (2021) · Substance Use & Misuse · doi:10.1080/10826084.2021.1954023 · Cited by 4
“With an estimated 2.6% prevalence of lifetime injection drug use among the US population, there is a sustained need for the implementation of evidence-based interventions designed to reduce high-risk injection practices (Lansky et al., 2014).”
BackgroundInfluentialOperative Management of Spinal Infection Among Intravenous Drug Abusers
Reid, D. B. C., Haglin, J. M., Durand, W. M., & Daniels, A. H. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2018.12.151 · Cited by 4
HIV infection and frequency of micronucleus in human peripheral blood cells
Zizza, A. (2019) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2019.60.3.1054 · Cited by 4
Integrating harm reduction into acute care: A single center's experience
Hyde, E. K., Nguyen, T., Gilchrist, S., & Lee-Ameduri, K. (2023) · JTCVS Open · doi:10.1016/j.xjon.2023.05.005 · Cited by 4
Nishizawa, M., Djurasovic, M., Glassman, S. D., Dimar, J. R., Crawford, C. H., Gum, J. L., Owens, R. K., Mathew, J., Kostic, B. A., & Carreon, L. Y. (2025) · The Spine Journal · doi:10.1016/j.spinee.2025.07.025 · Cited by 4
Prabhakar, A. M., Staziaki, P. V., Takx, R. A. P., & Ghoshhajra, B. B. (2015) · International journal of cardiac imaging · doi:10.1007/s10554-015-0719-6 · Cited by 4
Jordan, A. E., & Perlman, D. C. (2016) · Substance Use & Misuse · doi:10.1080/10826084.2016.1225767 · Cited by 4
“Alternatively, it is also possible that removing IDU from the HCV discourse could simultaneously serve both some interests of the private-sector and of PWID themselves by making HCV testing efforts and the inclusion of HCV treatment agents in public insurance formularies more socially and politically palatable.”
BackgroundInfluentialMental Health in Chronic and End-Stage Liver Disease
Nash, R. P., Golden, E., Dew, M. A., & DiMartini, A. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-94914-7_12 · Cited by 3
Resilience, Distress, and Dependence Influence Injection Related Risk among People Who Inject Drugs
Fisher, K. A., Phillippi, S. W., & Robinson, W. T. (2018) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-018-9955-z · Cited by 3
Collins, C. B., Baack, B. N., Tomlinson, H. L., Lyles, C., Cleveland, J. C., Purcell, D. W., Ortiz-Ricard, A., & Mermin, J. (2019) · AIDS and Behavior · doi:10.1007/s10461-019-02433-8 · Cited by 3
Murphy, M., Rogers, B. G., Chambers, L. C., Zanowick-Marr, A., Galipeau, D., Noh, M., Scott, T., Napoleon, S. C., Rose, J. S., & Chan, P. A. (2022) · AIDS Patient Care and STDs · doi:10.1089/apc.2022.0083 · Cited by 4
Clarke, S. E. D., Megerian, C. E., Suen, L. W., Wenger, L. D., Lambdin, B. H., Davidson, P. J., & Kral, A. H. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109686 · Cited by 5
Social disorganization theory and Hepatitis C incidence
Heilman, D. (2017) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 3
The Epidemiology of Injection Drug Use
Harrison, A., & Blonigen, D. M. (2017) · Psychiatric Annals · doi:10.3928/00485713-20161206-01 · Cited by 2
Rao, S., Song, W., Mulatu, M. S., Seena, E., Essuon, A. D., & Heitgerd, J. L. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa143 · Cited by 2
“Studies reveal that IDU is a major contributor to HIV and other infectious diseases in the United States and globally [8, 26].”
BackgroundShah, K. P., Srivastava, P., Modi, V. I., & Lier, A. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01129-0 · Cited by 2
“In a previous study, 50% of PWID were found to have HCV infection [32], aligning with our findings.”
Ceccato, V. A., Jorge, M. A., & Gliori, G. (2024) · Journal of Experimental Criminology · doi:10.1007/s11292-024-09652-7 · Cited by 2
“Most of our knowledge about drug use and trade comes from large urban areas (Ceccato et al., 2023; Lansky et al., 2014; Viana et al., 2011) and less so from small towns or rural areas (but see, e.g., Weisheit, 1993; Weisheit & Wells, 2010).”
En defensa de los programas de reducción de daños para usuarios de drogas inyectables
Kulikowski, J., & Linder, E. A. (2019) · Nursing (Ed española) · doi:10.1016/j.nursi.2019.01.011 · Cited by 2
Bars and nightclubs associated with higher HIV prevalence
Rossheim, M. E., Thombs, D. L., & Suzuki, S. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.08.024 · Cited by 2
Infectious Disease Complications in People Who Inject Drugs
Santoiemma, P. P., Dinwiddie, S. H., & Angarone, M. (2017) · Psychiatric Annals · doi:10.3928/00485713-20161206-03 · Cited by 2
Candidemia in the Growing Opioid Epidemic: A Distinct and Emerging Entity
Andes, D. R. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1065 · Cited by 2
The Surgical Treatment of Deep Infection in the Native Shoulder Joint.
Henry, T. W., Gutman, M. J., Backal, A., & Namdari, S. (2021) · PubMed Central · doi:10.22038/abjs.2020.50100.2484 · Cited by 2
Reimagining long‐term antibiotics in persons who inject drugs: Time to shift the status quo?
Theisen-Toupal, J. C., Rosenthal, E. S., & Rowley, C. F. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2581 · Cited by 2
“6 million individuals who have ever injected a drug.(1) The practice of IDU predisposes individuals to serious bacterial and fungal infections that”
BackgroundTerapia Cognitiva de las drogodependencias: nuevo estilo de vida durante la deshabituación
Ruiz, P. A. F., Cruz-Zúñiga, N., Vergara, C. I. H., Alvarado, J. R. M. ́., Chávez-Flores, Y. V., & Magallanes-Rodríguez, A. G. (2023) · Horizon Interdisciplinary Journal · doi:10.56935/hij.v1i2.17 · Cited by 1
Cutaneous Abscess Prevalence and Risk Factors Among People Who Inject Drugs in Denver, Colorado
Olson, N. L., Al‐Tayyib, A., & Rowan, S. E. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf165 · Cited by 1
“The number of individuals estimated to have injected nonprescription drugs in the US in 2018 was 3.7 million, a nearly 5-fold increase from the 774 000 estimated PWID in 2011 [4, 5].”
InfluentialCommon Bacterial Infections in Persons Who Inject Drugs
Lorenzo, M. P., Adams, K. K., & Housman, S. T. (2025) · Medicines · doi:10.3390/medicines12020008 · Cited by 1
Pulmonary hypertension in patients with a history of intravenous drug use
McGee, M., Whitehead, N., Twaddell, S. H., & Collins, N. J. (2019) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1558863 · Cited by 1
Metadata
- Authors
- Lansky, A., Finlayson, T., Johnson, C., Holtzman, D., Wejnert, C., Mitsch, A., Gust, D., Chen, R., Mizuno, Y., & Crepaz, N.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Lansky, Amy
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-05-19
- Volume
- 9
- Issue
- 5
- Pages
- e97596
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4026524
- OpenAlex
- W1996627792
- Cited by
- 235
- References
- 23
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 15 · 2022: 8 · 2021: 31 · 2020: 36 · 2019: 24 · 2018: 26 · 2017: 30 · 2016: 20 · 2015: 24 · 2014: 1
- FWCI
- 18.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- people who inject drugs, HIV infection rates, population size estimation, HIV surveillance, health disparities, United States
- MeSH terms
- Adolescent, Adult, Female, Hepatitis C, Humans, Male, Middle Aged, United States, HIV Infections, Substance Abuse, Intravenous, Drug Users, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
